期刊文献+

磁共振体素内不相干运动扩散加权成像在肺癌所致肺不张影像诊断中的初步应用 被引量:9

Preliminary Study of Intravoxel Incoherent Motion Diffusion Weighted MR Imaging for Differentiation Diagnosis of Lung Cancer from Lobar Collapse
原文传递
导出
摘要 目的:探讨磁共振体素内不相干运动扩散加权成像(intravoxel incoherent motion diffusion weighted MR Imaging,IVIM-DWI)在肺癌所致肺不张的影像诊断中的初步应用。方法:选取独立肺段肺不张病变患者43例,其中肺癌致肺不张31例(肺癌组),局部炎症致肺不张12例(炎症组)。所有患者在药物治疗或手术前均行3.0T磁共振IVIM-DWI检查,b值取0、50、100、200、400、600、800、1000 s/mm^2,分别测量灌注分数(perfusion fraction,f)、真实扩散系数(diffusion coefficient,D)以及关注相关扩散系数(diffusion coefficient from the perfused compartment,D*),对上述参数值进行相关统计学分析,并依据受试者工作特征曲线(Receiver Operating Characteristic,ROC)对各参数的评价效能进行分析。结果:肺癌组的D值、D*值以及f值分别为(0.64±0.16)×10^(-3)mm^2/s、(19.77±6.16)×10^(-3)mm^2/s以及(29.62±9.74)%,而炎症组的D值、D*值以及f值分别为(0.67±0.14)×10^(-3) mm^2/s、(21.14±8.32)×10^(-3)mm^2/s以及(47.62±11.46)%;经比较,肺癌组D值、D*值与炎症组无统计学差异(P>0.05),而二者f值差异显著,有统计学意义(P<0.01)。f值最佳阈值为38.42%,此时曲线下面积(Area Under Curve,AUC)为0.94,诊断肺癌的特异度为0.89,敏感度为0.93,阳性预测值为0.92,阴性预测值为0.89。结论:磁共振IVIM-DWI技术在肺癌所致肺不张的影像诊断中具有一定的应用价值。 Objective: To investigate the preliminary study of intravoxel incoherent motion diffusion weighted MR imaging (IVIM-DWI) in differentiation diagnosis of lung cancer from lobar collapse. Methods: 38 patients (31 cases of central lung cancer, 12 cases of infectious granuloma)with solitary pulmonary lesions were selected. All cases were examined with IVIM-DWI sequence before operation or medication, b-values was0, 25, 50,7 5,100, 200,400, 600, 800, 1000 s/mm2 respectively. The parameters of diffusion coefficient (D), diffusion coefficient from the perfused compartment (D*) and perfusion fraction (f) of all lesions was calculated.The diagnostic efficiency of each parameter of ROC curve is plotted. Results: The D,D* and f value of malignant group was (0.64±0.16)×10.3 minE/s, (19.77± 6.16)×10.3 mm2/s and (29.62± 9.74)%, And the benign group was (0.67±0.14)× 10-3mm2/s, (21.14± 8.32)×10-3mm2/s and (47.62± 11.46)% respectively. There was no significant difference between malignant group and benign group for D and D*(P〉0.05), but the value of f was significantly lower in malignant group comparing with benign group(P〈0.01). The cut-off of f values was 38.42%,and the area under the ROC of the f values was 0.94, The specificity,sensitivity, Positive predictive value and Negative predictive value in the diagnosis of lung cancer was 0.89, 0.93, 0.92, 0.89 respectively. Conclusions: The fvalue of IVIM-DWI is helpful in diagnosis of lung cancer from lobar collapse.
出处 《现代生物医学进展》 CAS 2016年第4期734-737,共4页 Progress in Modern Biomedicine
基金 河南省青年科技基金支持项目(HK14QK106)
关键词 肺癌 肺不张 体素内不相干运动 扩散加权成像 Lung cancer Lobar collapse Intravoxel Incoherent Motion Diffusion weighted MR imaging
  • 相关文献

参考文献3

二级参考文献24

  • 1齐丽萍,张晓鹏,唐磊,孙应实,汪宁.扩散加权成像用于中央型肺癌与肺不张鉴别的初步研究[J].中国医学影像技术,2007,23(10):1486-1490. 被引量:29
  • 2McCoach CE, Kelly K. Treatment paradigms in advanced non-small-cell lung cancer[J]. Clin Adv Hematol Oncol, 2013, 11 (10): 629-639.
  • 3Slomski. Lung cancers over diagnosed with low-dose CT[J]. JAMA, 2014,311(4): 349.
  • 4Aberle DR, Adams AM, Berg CD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening[J]. N Engl J Med, 2011,365:395-409.
  • 5AshrafH, Saghir Z, Dirksen A, et al. Smoking habits in the randomized Danish Lung Cancer Screening Trial with low-dose CT: final results after a 5-year screening programme[J]. Thorax, 2014, 17[Epub ahead of print].
  • 6Dhopeshwarkar MR, Roberts HC, Paul NS, et al. Screen detected lung cancer: a retrospective analysis of CT appearance[J]. Acad Radiol, 2011,18(2): 1270-1276.
  • 7Veronesi G, Pelosi G, Sonzogni A, et al. Turnour CEA as predictor of better outcome in squamous cell carcinoma of the lung[J]. Lung Can- cer, 2005, 48(2): 233-240.
  • 8Bugalho A, Martins C, Dias SS, et al. Cytokeratin 19, carcinoembryonic antigen, and epithelial cell adhesion molecule detect lung cancer lymph node metastasis in endobronchial ultrasound-guided transbronchial aspiration samples[J]. Clin Lung Cancer, 2013, 14 (6): 704-712.
  • 9Ono A, Takahashi T, Mori K, et al. Prognostic impact of serum CYFRA 21-1 in patients with advanced lung adenocarcinoma: a retrospective study[J]. BMC Cancer, 2013, 23, 13: 354.
  • 10Patz Jr EF, Campa MJ, Gottlin EB, et al. Panel of serum biomarkers for the diagnosis of lung cancer[J]. J Clin Oncol, 2007, 25 (22): 5578-5583.

共引文献59

同被引文献63

引证文献9

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部